yttrium radioisotopes has been researched along with Pleural Effusion in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avril, N; Jacobs, SA; Joyce, J; McCook, B; Torok, F; Vidnovic, N | 1 |
Austgen, M; Schlimmer, P; Trendelenburg, F; Wilhelm, H | 1 |
Austgen, M | 1 |
1 trial(s) available for yttrium radioisotopes and Pleural Effusion
Article | Year |
---|---|
Full-dose 90Y ibritumomab tiuxetan therapy is safe in patients with prior myeloablative chemotherapy.
Topics: Adult; Age Factors; Aged; Antibodies, Monoclonal; Antigens, CD20; Blood Platelets; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Platelet Count; Pleural Effusion; Positron-Emission Tomography; Radioimmunotherapy; Recurrence; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
2 other study(ies) available for yttrium radioisotopes and Pleural Effusion
Article | Year |
---|---|
Palliative therapy of tumor-induced pleural effusions with 90Yttrium-silicate.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Palliative Care; Pleural Effusion; Pleural Neoplasms; Silicates; Yttrium; Yttrium Radioisotopes | 1984 |
[Palliative therapy of tumor-induced pleural effusions with radioisotopes].
Topics: Adult; Aged; Brachytherapy; Female; Humans; Male; Middle Aged; Palliative Care; Pleural Effusion; Pleural Neoplasms; Silicates; Silicic Acid; Thoracoscopy; Yttrium; Yttrium Radioisotopes | 1989 |